Medpace Holdings (MEDP) Other Non-Current Assets (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Non-Current Assets came in at $25.2 million in Q2 2026, up 5.86% on a YoY basis from $23.8 million in Q2 2025, and down 11.02% quarter-over-quarter from $28.3 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Other Non-Current Assets for 12 consecutive years, with $25.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 5.86% year-over-year to $25.2 million; the trailing twelve-month figure through Jun 2026 stood at $25.2 million (up 5.86% YoY), and the FY2025 full-year result was $21.9 million, down 1.42% from the prior year.
- Other Non-Current Assets slipped to $25.2 million in Q2 2026 per MEDP's latest filing, from $28.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $28.3 million in Q1 2026 and bottomed at $18.5 million in Q2 2024.
- Historically, Other Non-Current Assets has averaged $22.2 million across 5 years, with a median of $22.0 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 49.16% in 2022, then dropped 17.12% in 2024.
- Over 5 years, Other Non-Current Assets stood at $21.1 million in 2022, then grew by 18.18% to $25.0 million in 2023, then slipped by 10.88% to $22.3 million in 2024, then retreated by 1.42% to $21.9 million in 2025, then climbed by 14.85% to $25.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $25.2 million, $28.3 million, and $21.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 117.41 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 587.56 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 201,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 91,801.74 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.20 Mn |
| Mar 31, 2026 | 28.32 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 25.72 Mn |
| Jun 30, 2025 | 23.80 Mn |
| Mar 31, 2025 | 21.52 Mn |
| Dec 31, 2024 | 22.25 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 18.45 Mn |
| Mar 31, 2024 | 20.41 Mn |
| Dec 31, 2023 | 24.97 Mn |
| Sep 30, 2023 | 20.83 Mn |
| Jun 30, 2023 | 22.26 Mn |
| Mar 31, 2023 | 22.03 Mn |
| Dec 31, 2022 | 21.13 Mn |
| Sep 30, 2022 | 18.63 Mn |
| Jun 30, 2022 | 19.12 Mn |
| Mar 31, 2022 | 19.48 Mn |
| Dec 31, 2021 | 17.42 Mn |
| Sep 30, 2021 | 16.49 Mn |